E-LIB Suche - Ergebnisse für: Diefenbach, Catherine

1

Polatuzumab vedotin plus rituximab and lenalidomide in pati..:

Abrisqueta, Pau ; González-Barca, Eva ; Panizo, Carlos...
The Lancet Haematology. 11 (2024) 2 - p. e136-e146 , 2024

Link: https://doi.org/10.1016/..

2

The Role of Autologous Stem-cell Transplantation in Classic..:

Varma, Gaurav ; Diefenbach, Catherine
Seminars in Hematology. , 2024

Link: https://doi.org/10.1053/..

3

Checkpoint Inhibitors Based Salvage Regimens Lead to Higher..:

Desai, Sanjal H ; Spinner, Michael A ; David, Kevin...
Transplantation and Cellular Therapy. 29 (2023) 2 - p. S32-S33 , 2023

Link: https://doi.org/10.1016/..

4

Overall survival of patients with cHL who progress after au..:

Desai, Sanjal H. ; Spinner, Michael A ; Evens, Andrew M....
Blood Advances. 7 (2023) 23 - p. 7295-7303 , 2023

Link: https://doi.org/10.1182/..

5

Phase 1/2 study of PRO1160, a CD70-directed antibody-drug c..:

Jonasch, Eric ; Call, Justin ; Kambhampati, Swetha...
The Oncologist. 28 (2023) Supplement_1 - p. S14-S15 , 2023

Link: https://doi.org/10.1093/..

6

Checkpoint inhibitor‐based salvage regimens prior to autolo..:

Desai, Sanjal H. ; Spinner, Michael A. ; David, Kevin...
American Journal of Hematology. 98 (2023) 3 - p. 464-471 , 2023

Link: https://doi.org/10.1002/..

7

Mosunetuzumab with polatuzumab vedotin in relapsed or refra..:

Budde, Lihua E. ; Olszewski, Adam J. ; Assouline, Sarit...
Nature Medicine. 30 (2023) 1 - p. 229-239 , 2023

Link: https://doi.org/10.1038/..

8

A genome-scale screen for synthetic drivers of T cell proli..:

Legut, Mateusz ; Gajic, Zoran ; Guarino, Maria...
Nature. 603 (2022) 7902 - p. 728-735 , 2022

Link: https://doi.org/10.1038/..

9

Safety and efficacy of atezolizumab with obinutuzumab and b..:

Younes, Anas ; Burke, John M. ; Diefenbach, Catherine...
Blood Advances. 6 (2022) 20 - p. 5659-5667 , 2022

Link: https://doi.org/10.1182/..

10

T100: Long term Follow-up of a Phase I Study Combinations o..:

Diefenbach, Catherine ; Jegede, Opeyemi ; Ambinder, Richard...
HemaSphere. 6 (2022) - p. 46-47 , 2022

Link: https://doi.org/10.1097/..

11

Anti-CD79B Antibody–Drug Conjugate DCDS0780A in Patients wi..:

Herrera, Alex F. ; Patel, Manish R. ; Burke, John M....
Clinical Cancer Research. 28 (2022) 7 - p. 1294-1301 , 2022

Link: https://doi.org/10.1158/..

12

Poster: IBCL-373: Updated Experience from Mosunetuzumab in ..:

Assouline, Sarit ; Kim, Won Seog ; Sehn, Laurie H....
Clinical Lymphoma Myeloma and Leukemia. 21 (2021) - p. S245 , 2021

Link: https://doi.org/10.1016/..

13

IBCL-373: Updated Experience from Mosunetuzumab in Multiple..:

Assouline, Sarit ; Kim, Won Seog ; Sehn, Laurie H....
Clinical Lymphoma Myeloma and Leukemia. 21 (2021) - p. S406-S407 , 2021

Link: https://doi.org/10.1016/..

14

Outcomes of Burkitt lymphoma with central nervous system in..:

Zayac, Adam S. ; Evens, Andrew M. ; Danilov, Alexey...
Haematologica. 106 (2021) 7 - p. 1932-1942 , 2021

Link: https://doi.org/10.3324/..

15

ABCL-351: Promising Tolerability and Efficacy Results from ..:

Budde, Elizabeth ; Ghosh, Nilanjan ; Chavez, Julio...
Clinical Lymphoma Myeloma and Leukemia. 21 (2021) - p. S393-S394 , 2021

Link: https://doi.org/10.1016/..